SEC Comment Letter for TRANSENTERIX, INC. (TRXDW) (CIK 0000876378) — May 22, 2020
TRANSENTERIX, INC. (TRXDW) (CIK 0000876378)
Date: May 22, 2020 · CIK: 0000876378 · Accession: 0000000000-20-004570
AI Filing Summary & Sentiment
File numbers found in text: 333-238471
Letter
United States securities and exchange commission logo May 21, 2020 Anthony Fernando Chief Executive Officer TransEnterix, Inc. 635 Davis Drive, Suite 300 Morrisville, NC 27560 Re:TransEnterix, Inc. Registration Statement on Form S-1 Filed May 18, 2020 File No. 333-238471 Dear Mr. Fernando: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason L. Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary J. Mullany, Esq.
Show Raw Text
United States securities and exchange commission logo
May 21, 2020
Anthony Fernando
Chief Executive Officer
TransEnterix, Inc.
635 Davis Drive, Suite 300
Morrisville, NC 27560
Re:TransEnterix, Inc.
Registration Statement on Form S-1
Filed May 18, 2020
File No. 333-238471
Dear Mr. Fernando:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason L. Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mary J. Mullany, Esq.